Pupillary dilation a must for OCT

Article

High quality optical coherence tomography (OCT) images cannot be obtained in a large percentage of glaucoma patients without pupillary dilation.

High quality optical coherence tomography (OCT) images cannot be obtained in a large percentage of glaucoma patients without pupillary dilation, according to a report published in the December issue of the British Journal of Ophthalmology.

Michael Smith from Torbay Hospital, Devon, UK and colleagues from the Peninsula Medical School and the University of Plymouth, Devon conducted an observational study of 38 patients attending a glaucoma clinic in order to examine the effect of pupillary dilation on the reliability of retinal nerve fibre layer (RNFL) and optic nerve head (ONH) assessments using the Stratus OCT (Carl Zeiss). The "fast optic disc" and "fast RNFL thickness" programmes on the Stratus were used to measure the RNFL thickness and ONH cup-to-disc ratio (CDR). Two scans were performed prior to dilation and two following dilation with tropicamide 1% drops.

In nine patients (23.7%) no images were obtained prior to dilation however, following dilation, examination was possible in all patients. Inability to obtain an undilated scan was associated with smaller pupil size and increasing cataract. The scan quality, as determined by the signal strength score, was higher when pupils were dilated for both RNFL thickness (p=0.011) and ONH CDR (p=0.007).

The authors of this study believe that attaining high quality OCT images is not possible without pupillary dilation, in about 25% of patients.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.